Steroid study seeks clues to prevent preemie lung disease

NCT ID NCT01854840

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 127 pregnant women who received a steroid called betamethasone to help prevent lung problems in their premature babies. Researchers measured how much of the drug reached the baby and whether it reduced the risk or severity of hyaline membrane disease, a serious breathing condition. The goal was to better understand the link between drug transfer and newborn lung health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN RECEIVE CELESTEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Necker Hospital

    Paris, 75015, France